Microinjection of transforming p21 ras protein induces maturation of Xenopus laevis oocytes, and the induction is blocked by coinjection of monoclonal antibody (Y13-259) against p21 ras proteins. Similar to other inducing agents, the effect of p21 ras protein is mediated via the appearance of maturation or meiosispromoting factor activity. In addition, the neutralizing antibody markedly reduces oocyte maturation after insulin induction, whereas it fails to inhibit progesterone induction. Our results suggest that insulin induces maturation of oocytes via a different pathway than that of steroidal agents. The induction by insulin is ras dependent, and the action of ras may be directed at the steps before meiosis-promoting factor autocatalytic activation. These results suggest a role of p21 ras protein in the events associated with amphibian oocyte maturation.
maturation of oocytes via a different pathway than that of steroidal agents. The induction by insulin is ras dependent, and the action of ras may be directed at the steps before meiosis-promoting factor autocatalytic activation. These results suggest a role of p21 ras protein in the events associated with amphibian oocyte maturation.
The ras family forms a group of closely related transforming genes that are highly conserved in eucaryotes (5, 11, 18, 28, 34, 48) . Normal (cellular) ras genes acquire transforming properties by single point mutations within their coding sequences (4, 32, 33, 41, (45) (46) (47) 54) , and these mutated ras genes have been detected in a significant fraction of human cancers as well as in experimentally induced animal tumors (45, 48, 54) . It has been speculated that p21 ras proteins are essential components of normal cells that are involved in cell division and differentiation (30, 31 ). Yet, little is known regarding the mechanisms by which p21 proteins induce malignant transformation, and even less is known regarding their role in normal cells.
It has been demonstrated that p21 proteins can induce transformation of NIH 3T3 cells when introduced by microinjection (13, 44) and that the transforming activity of the ras proteins can be blocked by coinjection with monoclonal antibody Y13-259 (19) . Recently, Birchmeier et al. (3) have shown that ras proteins can induce meiosis in Xenopus laevis oocytes. Fully grown oocytes can be easily injected and analyzed biochemically. Oocytes surgically removed from adult Xenopus ovaries are arrested in the prophase of meiosis and can be triggered to undergo meiosis by treatment with progesterone, insulin, and a variety of other agents. In the present study, we determined the effect of injected neutralizing antibody (Y13-259) on the maturation of oocytes.
Gravid X. laevis females were obtained from Nasco Co. (Fort Atkinson, Wis.) and maintained under laboratory conditions (9) . Ovarian fragments were surgically removed from frogs that were anesthetized by hypothermia. Fully grown stage VI oocytes were manually dissected, and follicle cells were removed after collagenase treatment of ovarian fragments at 21°C following the procedure of Eppig and Dumont (12) (2) was not included in the MBSH. Normal and transforming human H-ras proteins were purified from Escherichia coli containing an expression plasmid (20, 23) . After injection of purified p21 proteins into Xenopus oocytes, we confirmed the recent findings that transformipg p21 protein (40 ng) induces the maturational meiotic process (Fig. 1) . After injection of transforming p21 protein and overnight incubation at 21°C, we consistently observed over 80% of the oocytes entering the maturational meiotic process. Routinely, induction of oocyte maturation was judged by the appearance of the white depigmented Roux's spot (germinal vesicle breakdown [GVBD] ) in the animal pole after 18 h of incubation ( Fig. 1 ) (14, 26, 49) and further confirmed by dissecting oocytes fixed in 5% trichloroacetic acid under a binocular microscope for the absence of the germinal vesicle (6) . Normal cellular p21 protein was less effective. In four separate experiments, injection of normal cellular p21 protein (40 ng) induced less than 6% of oocytes to enter the maturational meiotic process. The induction of oocyte maturation by transforming p21 protein was blocked by coinjection with monoclonal antibody (Y13-259) against p21 proteins (data not shown).
Several oocyte maturation-inducing agents were tested, including progesterone, 17a-hydroxy-20f-dihydroprogesterone (17a-20tdHPR), and insulin. Stock solutions of agents were prepared in appropriate solvents and were added directly to MBSTI to obtain the desired effective final concentration (7, 37, 49, 52, 53) . It has been known for some time that a variety of steroid and peptide hormones can induce oocyte maturation in amphibians. Progesterone and 17a-20,dHPR are fully effective in inducing GVBD at a concentration of 3 p.M (99.3 and 100% effective, respectively), and insulin is effective at a concentration of 7 FM (80% effective). In the case of progesterone or other steroid hormones, they must interact first with the outer surface of the oocyte to initiate the chain of biochemical reactions leading to maturation, possibly by calcium movements or translocation from membrane stores or both (16, 24-26, 38-40, 52). It has been suggested that the induction of oocyte maturation with steroids is a two-step process, first involving interaction of steroids at a site in or near the oocyte surface, followed by the appearance of cytoplasmic meiosis-or maturation-promoting factor (MPF) (1, 51) . Similarily, the peptide hormone insulin also induces oocyte maturation by first reacting with the outer surface of the oocyte (10, 21, 50) . It has been demonstrated that both progesterone and insulin fail to initiate maturational events upon microinjection (1, 17, 21, 24, 42) .
To characterize the events associated with amphibian oocyte maturation, Dettlaff et al. (8) first reported that nuclear sap taken from the germinal vesicle of Bufo viridis oocytes at the time of GVBD could induce nuclear dissolution when microinjected back into oocytes not previously exposed to hormones. Subsequent observations have demonstrated that this MPF resides in the cytoplasm of maturing oocytes of Rana pipiens (24, 42) and X. laevis (35, 38, 51) . The appearance of MPF activity was monitored in mature oocytes after p21 injection or hormone induction. Thirty oocytes were injected with transforming p21 protein (40 ng) or treated with hormones (3 ,uM of progesterone or 7 ,M of insulin) and cultured in MBSH at 21°C for 18 h. Controls were untreated or buffer-injected oocytes. Cytosols were prepared by the method described by Deshpande and Koide (6, 7) . Thirty untreated oocytes were microinjected with 60 nl of crude MPF extract and incubated in MBSH at 21°C for 18 h. GVBD was monitored as described in the text and Fig.  1 . The percentage of cells with GVBD was as follows: controls, 0%; p21-injected oocytes, 87%; progesteroneinduced oocytes, 100%; and insulin-induced oocytes, 95%. We were able to detect MPF activity by microinjecting cytosols from matured oocytes into untreated oocytes by the methods of Masui and Markert (24) and Deshpande and Koide (6) . In addition, it has been demonstrated that repeated serial transfers of cytoplasm from maturing donor oocytes continued to induce maturation in secondary and tertiary recipients even though the initial donor oocyte was the only one injected with p21 or exposed to hormones. This result suggested that MPF was continually amplified during each successive passage, somewhat analogous to an autocatalytic reaction.
To better understand the mode of action of p21 ras proteins on the induction of oocyte maturation, we observed the behavior of cells from which the endogenous ras proteins had been removed. Monoclonal antibody (Y13-259) prepared against Harvey murine sarcoma virus ras proteins is known to react with both cellular and viral (Harvey and Kirsten) ras gene products as well as with yeast ras proteins (15, 29, 32, 47) . Because of the observed conservation of ras genes in eucaryotes, it is possible to remove endogenous ras proteins from Xenopus oocytes via microinjection of Y13-259 antibody (19, 36) . Various GVBD-inducing agents were tested for their susceptibility to inhibition by antibody Y13-259. In each experimental group, oocytes from a single female were used to reduce variations in individual response. The oocytes were first microinjected with increasing concentrations of antibody Y13-259 (100, 200, and 400 ng per oocyte), and groups of 20 to 25 oocytes were exposed to GVBDinducing agents. A general pattern of response was observed in oocytes from four females (Fig. 2) . Antibody Y13-259 by itself did not induce oocyte maturation in 400 oocytes tested at any of the concentrations of antibody used. Recently, Sadler et al. (36) have reported that monoclonal antibodies to ras protein accelerate progesterone-induced GVBD. In the present studies, we observed that antibody Y13-259 at the three different concentrations used failed to inhibit progesterone-or 17 a-20fidHPR-induced GVBD. However, insulininduced GVBD was consistently inhibited in an antibodyconcentration-dependent manner.
Any conclusions drawn from the present study depend on the specificity of the cellular proteins neutralized by antibody Y13-259. All the presently available evidence indicates that it is in fact the ras proteins which are neutralized by microinjection of antibody Y13-259 into NIH 3T3 cells (19, 27, 30, 43 (19, 27) . We have also isolated several transformation-competent mutation ras genes whose protein products in transformed NIH 3T3 cells are not immunoprecipitated by this monoclonal antibody (30 (43) . The present study, whose results were obtained in a totally different system, ties in very nicely with previous studies (l, 27, 43) on the possible requirement of ras for initiation of the S phase in NIH 3T3 cells and for transformation of NIH 3T3 cells by certain genes of the tyrosine kinase family.
While it was clear that insulin and steroids interacted with the outer surface of the oocyte to initiate biochemical reactions leading to the activation and amplification of MPF which in turn is involved in further events leading to maturation, microinjection studies indicated that the induction of oocytq maturation by injected p21 ras protein was also mediated via production of MPF. The injected neutralizing antibody (Y13-259) markedly reduced oocyte maturation induced by insulin, whereas it failed to inhibit induction by the steroid hormone progesterone which is known to be a natural initiator of oocyte maturation in amphibians. These results suggest that insulin and progesterone initially induce oocyte maturation via two different modes of actions, but presumably both ultimately lead to the production of MPF. Since both insulin and progesterone induced MPF formation, the inhibitory action of the antibody Y13-259 on the instilin induction of oocyte maturation may be directed at the steps before MPF synthesis, and the induction by insulin is ras dependent. Detailed biochemical analysis of the inhibitory action of antibody Y13-259 on the insulin induction of oocyte maturation should provide us with a better understanding of the observations which have emerged from this study.
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